A Phase 1, Randomized, Double Blind, Placebo Controlled, Single and Multiple Dose Escalation Study in Healthy Volunteers and an Expansion cohort in Adult Participants with Amyotrophic Lateral Sclerosis (ALS) to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPG302

  • Rowe, Dominic (Primary Chief Investigator)
  • Kalband, Balaji (Associate Investigator)
  • Delcourt, Candice (Associate Investigator)
  • Gan, Richard (Research Coordinator)
  • Bayeh, Paula (Research Coordinator)

Project: Research

Project Details

Short titleSPG302-ALS-001
Effective start/end date1/05/2419/04/29